ArticleNeuro-oncology advances

Phase 1 trial of hypofractionated stereotactic re-irradiation in combination with nivolumab, ipilimumab, and bevacizumab for recurrent high-grade gliomas.

Solmaz Sahebjam et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.